Ellis, Lee M.

VEGF-targeted therapy: mechanisms of anti-tumour activity

Ellis, L. M., & Hicklin, D. J. (2008) · Nature Reviews Cancer

Angiogenesis and VEGF in CancerLymphatic System and Diseases

Cited by 1,673

Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

Niu, G., Wright, K. L., Huang, M., Song, L., Haura, E., Turkson, J., Zhang, S., Wang, T., Sinibaldi, D., Coppola, D., et al. (2002) · Oncogene

Angiogenesis and VEGF in CancerCytokine Signaling Pathways and Interactions

Cited by 1,207

Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018

Loree, J. M., Anand, S., Dasari, A., Unger, J. M., Gothwal, A., Ellis, L. M., Varadhachary, G., Kopetz, S., Overman, M. J., & Raghav, K. (2019) · JAMA Oncology

Ethics in Clinical ResearchRace, Genetics, and Society

Cited by 570

Pathways Mediating Resistance to Vascular Endothelial Growth Factor–Targeted Therapy

Ellis, L. M., & Hicklin, D. J. (2008) · Clinical Cancer Research

Angiogenesis and VEGF in CancerCancer, Hypoxia, and Metabolism

Cited by 257

Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress

Kopetz, S., Lesslie, D. P., Dallas, N. A., Park, S. I., Johnson, M., Parikh, N. U., Kim, M. P., Abbruzzese, J. L., Ellis, L. M., Chandra, J., et al. (2009) · Cancer Research

Colorectal Cancer Treatments and StudiesCancer Mechanisms and Therapy

Cited by 160

Finding the tumor copycat: Therapy fails, patients don’t

Ellis, L. M., & Fidler, I. J. (2010) · Nature Medicine

Cancer Cells and MetastasisVeterinary Oncology Research

Cited by 109

From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology

Raghav, K. P. S., Mahajan, S., Yao, J. C., Hobbs, B. P., Berry, D. A., Pentz, R. D., Tam, A., Hong, W. K., Ellis, L. M., Abbruzzese, J., et al. (2015) · Journal of Clinical Oncology

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 59

Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2

Chang, K., Willis, J. A., Reumers, J., Taggart, M. W., San Lucas, F. A., Thirumurthi, S., Kanth, P., Delker, D. A., Hagedorn, C. H., Lynch, P. M., et al. (2018) · Annals of Oncology

Genetic factors in colorectal cancerColorectal Cancer Treatments and Studies

Cited by 51

A Framework for Improving the Quality of Research in the Biological Sciences

Casadevall, A., Ellis, L. M., Davies, E. W., McFall-Ngai, M., & Fang, F. C. (2016) · mBio

Academic Publishing and Open AccessAcademic integrity and plagiarism

Cited by 46

A survey on data reproducibility and the effect of publication process on the ethical reporting of laboratory research

Boulbes, D. R., Costello, T., Baggerly, K., Fan, F., Wang, R., Bhattacharya, R., Ye, X., & Ellis, L. M. (2018) · Clinical Cancer Research

Academic integrity and plagiarismAcademic Publishing and Open Access

Cited by 41